Lukin D, Faleck D, Xu R, Zhang Y, et al. Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis. Clin Gastroenterol Hepatol 2020 Oct 8. pii: S1542-3565(20)31388.
PMID: 33039584